Biotricity Statistics
Want to see BTCY full AI Analyst Report?
Biotricity (BTCY) Stock Statistics & Valuation Metrics
Total Valuation
Biotricity has a market cap or net worth of $1.31M. The enterprise value is $33.48M.
- Market Cap
- $1.31M
- Enterprise Value
- $33.48M
Share Statistics
Biotricity has 21,631,493 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 21,631,493
- Owned by Insiders
- ―
- Owned by Institutions
- 0.22%
Financial Efficiency
Biotricity’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -37.57%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- -0.37
- Return on Invested Capital (ROIC)
- -37.57%
- Return on Capital Employed (ROCE)
- -0.06
- Revenue Per Employee
- 347.79K
- Profits Per Employee
- -52.26K
- Employee Count
- 46
- Asset Turnover
- 2.48
- Inventory Turnover
- 2.27
Valuation Ratios
The current PE Ratio of Biotricity is -0.44. Biotricity’s PEG ratio is -0.01.
- PE Ratio
- -0.44
- PS Ratio
- 0.07
- PB Ratio
- -0.04
- Price to FCF
- 7.01
- Price to Operating Cash Flow
- 8.13
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Biotricity had revenue of 16.00M and earned -2.40M in profits. Earnings per share was -0.11.
- Revenue
- 16.00M
- Gross Profit
- 12.95M
- Operating Income
- 1.69M
- Pretax Income
- -2.40M
- Net Income
- -2.40M
- EBITDA
- 2.44M
- Earnings Per Share (EPS)
- -0.11
Cash Flow
In the last 12 months, operating cash flow was 161.66K and capital expenditures 5, giving a free cash flow of 161.66K billion.
- Operating Cash Flow
- 161.66K
- Free Cash Flow
- 161.66K
- Free Cash Flow per Share
- 0.01
Dividends & Yields
Biotricity pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 14.26%
- Earnings Yield
- -204.75%
Stock Price Statistics
- Beta
- 0.13
- 52-Week Price Change
- -89.53%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.15
- Relative Strength Index (RSI)
- 50.73
- Average Volume (3m)
- 49.79K
Important Dates
Biotricity upcoming earnings date is Nov 13, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Nov 13, 2026
- Next Earnings Date
- Nov 13, 2026
- Ex-Dividend Date
- ―
Financial Position
Biotricity as a current ratio of 0.16, with Debt / Equity ratio of -82.10%
- Current Ratio
- 0.16
- Quick Ratio
- 0.12
- Debt to Market Cap
- 4.20
- Net Debt to EBITDA
- 11.02
- Interest Coverage Ratio
- -0.50
Taxes
In the past 12 months, Biotricity has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Biotricity EV to EBITDA ratio is 14.87, with an EV/FCF ratio of 170.71.
- EV to Sales
- 1.68
- EV to EBITDA
- 14.87
- EV to Free Cash Flow
- 170.71
- EV to Operating Cash Flow
- 170.71
Balance Sheet
Biotricity has $466.50K in cash and marketable securities with $26.93M in debt, giving a net cash position of -$26.46M billion.
- Cash & Marketable Securities
- $466.50K
- Total Debt
- $26.93M
- Net Cash
- -$26.46M
- Net Cash Per Share
- -$1.22
- Tangible Book Value Per Share
- -$1.46
Margins
Gross margin is 81.47%, with operating margin of 9.56%, and net profit margin of -16.41%.
- Gross Margin
- 81.47%
- Operating Margin
- 9.56%
- Pretax Margin
- -16.41%
- Net Profit Margin
- -16.41%
- EBITDA Margin
- 11.32%
- EBIT Margin
- 8.57%
Analyst Forecast
The average price target for Biotricity is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 13.40%
- EPS Growth Forecast
- 43.26%
Scores
- Smart Score
- ―
- AI Score
- 44
